SCHEMBL3536868

SCHEMBL3536868

CS(=O)(=O)Nc1ccc(N)c(N2CCCCC2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.68
MAPK1 P28482 2/20 0.68
HPGD P15428 1/20 0.68
CSF1R P07333 1/20 0.52
ALDH1A1 P00352 3/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPT P10636 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
S100B P04271 2/20 0.51
LMNA P02545 1/20 0.51
PKM P14618 1/20 0.51
ALOX15 P16050 1/20 0.51
HTT P42858 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NPSR1 Q6W5P4 2/20 0.45
POLB P06746 1/20 0.45
MET P08581 1/20 0.45
KEAP1 Q14145 1/20 0.44
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26618182 0.85 KIF18A (0.49) GAAMAPK1HPGD
SCHEMBL3536866 0.81 GAA (0.61) GAAMAPK1HPGDCSF1RALDH1A1
SCHEMBL15894586 0.81 GAA (0.65) GAAMAPK1HPGDCSF1RALDH1A1
SCHEMBL3543840 0.80 GAA (0.59) GAAMAPK1HPGDALDH1A1MEN1
SCHEMBL5098532 0.77 CYP1A2 (0.59) GAAMAPK1HPGDALDH1A1MEN1
SCHEMBL16261606 0.74 MAPT (0.63) GAAMAPK1HPGDALDH1A1MEN1
SCHEMBL1530134 0.73 CA12 (0.52) GAAMAPK1HPGDALDH1A1LMNA
SCHEMBL28824858 0.73 MAPT (0.60) GAAMAPK1HPGDALDH1A1MEN1
SCHEMBL3534495 0.72 CSF1R (0.52) GAAMAPK1HPGDCSF1RALDH1A1
Sulfuric Acid SCHEMBL7809582 0.72 ALDH1A1 (0.57) GAAMAPK1HPGDALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP claimed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP claimed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US claimed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO claimed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP disclosed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US disclosed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100201-A1 Inhibitors of c-fms kinase MUSK, FLT3, FES GAA 3696/4885MAPK1 280/4885HPGD 4479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.